COLORADO SPRINGS, Colo., June 5 /PRNewswire-FirstCall/ -- Spectranetics Corporation today announced that it will participate in several investment conferences this month, including:
-- The Next Generation Equity Research Healthcare Investor Conference, Tuesday, June 12, 2007, at the Harvard Club in Boston. Spectranetics senior executives will participate in the format of a series of one-on- one and small group meetings throughout the day. -- The Sixth Annual Needham & Company Biotechnology and Medical Technology Conference, Wednesday, June 13, 2007, at the New York Palace Hotel. Spectranetics’ chief executive officer John G. Schulte is scheduled to present at 4:00 p.m. Eastern time. Interested parties can access a live audio webcast and slide presentation at http://www.spectranetics.com. An archived presentation will be available on the Web site for 14 days. -- The Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference, Thursday, June 14, 2007, at the Ritz-Carlton Laguna Niguel, in Dana Point, California. Mr. Schulte is scheduled to present at 10:40 a.m. Pacific time. Interested parties can access a live audio webcast and slide presentation at http://www.spectranetics.com. An archived presentation will be available on the Web site for 14 days. -- The Jefferies Healthcare Conference, Thursday, June 28, 2007, at the Mandarin Oriental Hotel in New York. Spectranetics’ Chief Financial Officer Guy A. Childs is scheduled to present at 3:10 p.m Eastern time. Interested parties can access a live audio webcast and slide presentation at http://www.spectranetics.com. An archived presentation will be available on the Web site for 14 days.
About Spectranetics
Founded in 1984, Spectranetics manufactures and sells the only excimer laser approved in the United States, Europe and Japan for use in minimally invasive cardiovascular procedures. This technology treats complex cardiovascular conditions by photo-ablating multiple lesion types into tiny particles that are easily absorbed into the blood stream. The Company’s disposable catheters use high-energy “cool” ultraviolet light to vaporize arterial blockages in the legs and heart, as well as scar tissue encapsulating pacing and defibrillation leads. For more information visit http://www.spectranetics.com.
COMPANY CONTACT: INVESTOR & MEDIA CONTACTS: Spectranetics Corporation Lippert/Heilshorn & Associates, Inc. Guy Childs, Chief Financial Officer Bruce Voss or Don Markley (719) 633-8333 (310) 691-7100 http://www.spectranetics.comhttp://www.lhai.com
Spectranetics Corporation
CONTACT: Guy Childs, Chief Financial Officer of Spectranetics Corporation,+1-719-633-8333; or investors & media, Bruce Voss or Don Markley, both ofLippert-Heilshorn & Associates, Inc., +1-310-691-7100, for SpectraneticsCorporation
Web site: http://www.spectranetics.com/
